Clinical Trials Browser

Mouth Diseases, Mouth Neoplasms

NCT00540774 2026-04-09

Optical Sensor for Photodynamic Detection of Oral Pathology

Phase NA Completed

1,004 enrolled

Head & Neck

Gingivitis, Mouth Diseases, Mouth Neoplasms, Periodontitis, Stomatitis, Xerostomia

NCT05911750 2025-09-12

PAPIMALE

Recruiting

384 enrolled

Mouth Diseases, Papillomavirus Infections

NCT06321003 2025-05-23

SYMILIS OCT

Recruiting

200 enrolled

DermatologicHead & Neck

Actinic cheilitis, Squamous Cell Carcinoma of Head and Neck, Graft vs Host Disease, Leukoplakia, Oral, Mouth Diseases, Mouth Neoplasms, Lichen Planus, Oral, Keratosis, Actinic

NCT05853783 2024-11-07

Evaluation of Oral Potentially Malignant Disorders (OPMDs) with STRATICYTE™

Recruiting

180 enrolled

Head & Neck

Disease, Erythroplasia, Hyperplasia, Leukoplakia, Mouth Diseases, Keratoderma, Palmoplantar, Epidermolytic

NCT05942794 2024-02-28

Identification of Oral Lesions Through an Autofluorescence System

Phase NA Unknown

200 enrolled

DermatologicHead & Neck

Carcinoma, Squamous Cell, Keratosis, Leukoplakia, Oral, Lichen Planus, Mouth Diseases, Mouth Neoplasms, Lichen Planus, Oral

NCT04153266 2020-04-02

ODIN-Q

Completed

128 enrolled

Head & NeckOther neoplasm

Leukoplakia, Oral, Stomatognathic Diseases, Mouth Diseases, Oral Submucous Fibrosis, Patient Participation, Precancerous Conditions, Health Behavior, Patient Satisfaction, Lichen Planus, Oral, Information Seeking Behavior, Patient Preference

NCT01604759 2017-01-31

PolProbe

Phase 1 Completed

40 enrolled

Head & Neck

Mouth Diseases, Mouth Neoplasms

NCT02870270 2016-08-19

Prospective Studies on Oral Health and Quality of Life in Head and Neck Cancer Patients

Completed

33 enrolled

Head & Neck

Mouth Diseases, Mouth Neoplasms

NCT02737176 2016-08-01

TISOD

Phase NA Unknown

812 enrolled

DermatologicHead & Neck

Keratosis, Leukoplakia, Lichen Planus, Mouth Diseases, Periodontal Diseases, Smoking Cessation

NCT00323518 2016-04-13

A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis

Phase 2 Completed

390 enrolled

Mouth Diseases, Stomatitis

NCT02262247 2016-03-16

A Post-Market Clinical Trial for Access and Visualization of the Oropharynx, Hypopharynx and Larynx During Transoral Procedures

Completed

80 enrolled

Head & Neck

Hypopharyngeal Neoplasms, Laryngeal Diseases, Mouth Diseases, Oropharyngeal Neoplasms

NCT00104065 2016-03-15

Safety and Efficacy of CG53135-05 in the Prevention of Oral Mucositis in Patients Receiving Bone Marrow Transplant

Phase 2 Completed

Mouth Diseases, Stomatitis

NCT01247246 2014-05-26

Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer

Phase 2 Unknown

160 enrolled

GastrointestinalHead & NeckOther

Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, Head and Neck Neoplasms, Stomatognathic Diseases, Mouth Diseases, Neoplasms, Neoplasms by Site, Stomatitis, Mucositis

NCT00230191 2007-01-15

Safety and Efficacy of RK0202 in Oral Mucositis

Phase 2 Completed

110 enrolled

Head & NeckOther

Head and Neck Neoplasms, Mouth Diseases, Stomatitis, Oral Ulcer, Mucositis

Clinical Trials

Multimodal Imaging for Surveillance in Patients With Oral Potentially Malignant Disorders

Optical Sensor for Photodynamic Detection of Oral Pathology

PAPIMALE

SYMILIS OCT

Evaluation of Oral Potentially Malignant Disorders (OPMDs) with STRATICYTE™

Identification of Oral Lesions Through an Autofluorescence System

ODIN-Q

PolProbe

Prospective Studies on Oral Health and Quality of Life in Head and Neck Cancer Patients

TISOD

A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis

A Post-Market Clinical Trial for Access and Visualization of the Oropharynx, Hypopharynx and Larynx During Transoral Procedures

Safety and Efficacy of CG53135-05 in the Prevention of Oral Mucositis in Patients Receiving Bone Marrow Transplant

Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer

Safety and Efficacy of RK0202 in Oral Mucositis